IL17A and diabetic kidney disease: The lack of significant differences in serum TGF-β, serum IL-17, and serum Mg levels between the genotypes suggests that these biomarkers may not be strongly influenced by the Calpain 10 SNP 19 genotype in diabetic nephropathy patients.